India covid-19 experts patient India

Covid-19: Dr Reddy's, Cipla, 3 more pharma firms partner for clinical trial of oral anti-viral drug

Reading now: 914
www.livemint.com

Cipla, Dr Reddy's, Emcure, Sun Pharma and Torrent Pharma announced on Tuesday that they will collaborate for the clinical trial of the investigational oral anti-viral drug Molnupiravir for the treatment of mild Covid-19 in an outpatient setting in India.

Between March and April this year, these five pharma companies had individually entered into a non-exclusive voluntary licensing agreement with Merck Sharpe Dohme (MSD) to manufacture and supply Molnupiravir to India and over 100 low and middle-income countries (LMICs).

The five pharma companies have entered into a collaboration agreement, wherein the parties will jointly sponsor, supervise and monitor the clinical trial in India.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA